OBJECTIVE: Clobazam is a newer 1, 5-benzodiazepine used for the treatment of epilepsy. It
is better tolerated and less sedating than other benzodiazepines. It has yet to gain wide use …

We report our experience with add-on clobazam therapy over a 5-year period in 63 children
with refractory epilepsy. The mean duration of epilepsy was 6.7 years. Children were …

Rationale: Clobazam has been used successfully in adults and children with partial
epilepsy. The purpose of this study was to evaluate the safety and efficacy of clobazam as …

We describe our experience using clobazam, examining efficacy for individual seizure types
and analyzing for factors contributing to initial and sustained response. We retrospectively …

Clobazam is a new benzodiazepine recently introduced in Canada on an experimental
basis. We report our experience with 27 children (average age 9.1 years) with severe …

Background Clobazam has been used in clinical practice as an adjunctive treatment for
diverse seizure types and epilepsy syndromes. We evaluated the efficacy and safety of …

Objective To evaluate the efficacy of clobazam in childhood refractory epilepsy and to
characterize the adverse drug reaction profile in the Indian population. Methods A cohort of …

The objective of this study was to evaluate the safety and efficacy of clobazam in children
with refractory focal epilepsy. We investigated 100 consecutive patients concerning etiology …

Clobazam, a 1, 5-benzodiazepine, was introduced in the 1970s as an anxiolytic and
antiepileptic drug. Despite worldwide usage, it was only recently approved in the United …

Abstract Clobazam is a 1, 5-benzodiazepine reported to have a wide spectrum of
antiepileptic activity and is associated with less neurotoxicity than the 1, 4-benzodiazepines …